Chapter 19. Aortic Valve Disease

  1. Mark J. D. Griffiths MRCP, PhD, EDICM, BDICM Consultant,
  2. Jeremy J. Cordingley MRCP, FRCA, EDICM Consultant and
  3. Susanna Price MRCP, PhD, EDICM, FESC Consultant
  1. Susanna Price MRCP, PhD, EDICM, FESC Consultant2 and
  2. Derek Gibson MD1

Published Online: 9 JUL 2010

DOI: 10.1002/9781444314502.ch19

Cardiovascular Critical Care

Cardiovascular Critical Care

How to Cite

Price, S. and Gibson, D. (2010) Aortic Valve Disease, in Cardiovascular Critical Care (eds M. J. D. Griffiths, J. J. Cordingley and S. Price), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314502.ch19

Editor Information

  1. Royal Brompton & Harefield NHS Foundation Trust London, UK

Author Information

  1. 1

    Department of Cardiology, Royal Brompton & Harefield NHS Foundation Trust, London, UK

  2. 2

    Royal Brompton & Harefield NHS Foundation Trust London, UK

Publication History

  1. Published Online: 9 JUL 2010
  2. Published Print: 30 JUL 2010

ISBN Information

Print ISBN: 9781405148573

Online ISBN: 9781444314502

SEARCH

Keywords:

  • Associated manifestations and co-morbidity;
  • AS as the primary indication for ICU admission;
  • Medical/surgical ICU admission not requiring surgery;
  • Mechanical prosthetic AVR malfunction;
  • Management of the patient immediately post AVR;
  • ICU having previously undergone AVR;
  • Bioprosthetic AVR malfunction;
  • inotropes may cause significant LVOTO

Summary

This chapter contains sections titled:

  • Introduction

  • Aortic stenosis

  • Aortic regurgitation

  • Aortic valve replacement

  • Management of the patient immediately post AVR

  • Conclusion

  • References